Paper28334136
A review of network-based approaches to drug repositioning.
Lotfi Shahreza M and 4 others. Brief Bioinform, 2018. Cited by 198 papers, by iCite.
Cite this record
ConductScience Library. A review of network-based approaches to drug repositioning. Papers, record 28334136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28334136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Repositioning | Major topic |
| Computational Biology | |
| Databases, Pharmaceutical | |
| Drug Interactions | |
| Drug-Related Side Effects and Adverse Reactions | |
| Gene Regulatory Networks | |
| Humans | |
| Machine Learning | |
| Metabolic Networks and Pathways | |
| Molecular Docking Simulation | |
| Protein Interaction Maps |
Source PubMed
Cited by131
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 198 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42739229 | Artificial Intelligence and Digital Biomarkers for Early Detection and Monitoring of Neurological Disorders: A Narrative Review. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42739229 | PubMed |
| 42470695 | Graph-based drug-target interaction modeling: from representation learning to output-driven drug discovery. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42470695 | PubMed |
| 42422048 | Enhanced drug-disease association prediction through representation learning on similarity networks. | Biol Methods Protoc | 2026 | https://conductscience.org/library/papers/42422048 | PubMed |
| 42249216 | NetPolicy-RL: network-informed offline reinforcement learning for pharmacogenomic drug prioritization. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42249216 | PubMed |
| 42079259 | An Agentic Platform for Drug Repurposing Unified across Molecular, Phenotypic, and Clinical Scales. | bioRxiv | 2026 | https://conductscience.org/library/papers/42079259 | PubMed |
| 41676020 | A comprehensive review of molecular optimization in artificial intelligence-based drug discovery. | Quant Biol | 2024 | https://conductscience.org/library/papers/41676020 | PubMed |
| 41155542 | Src and Abl as Therapeutic Targets in Lung Cancer: Opportunities for Drug Repurposing. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155542 | PubMed |
| 41100566 | Drug-disease networks and drug repurposing. | PLoS Comput Biol | 2025 | https://conductscience.org/library/papers/41100566 | PubMed |
| 40841559 | Improving computational drug repositioning through multi-source disease similarity networks. | Sci Rep | 2025 | https://conductscience.org/library/papers/40841559 | PubMed |
| 40678475 | Adaptive multi-view learning method for enhanced drug repurposing using chemical-induced transcriptional profiles, knowledge graphs, and large language models. | J Pharm Anal | 2025 | https://conductscience.org/library/papers/40678475 | PubMed |
| 40356956 | DTGHAT: multi-molecule heterogeneous graph transformer based on multi-molecule graph for drug-target identification. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40356956 | PubMed |
| 40290426 | Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40290426 | PubMed |
| 40102542 | A novel deep sequential learning architecture for drug drug interaction prediction using DDINet. | Sci Rep | 2025 | https://conductscience.org/library/papers/40102542 | PubMed |
| 40008124 | KGRDR: a deep learning model based on knowledge graph and graph regularized integration for drug repositioning. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40008124 | PubMed |
| 39819398 | Identifying Novel Therapeutic Opportunities for Dilated Cardiomyopathy: A Bioinformatics Approach to Drug Repositioning and Herbal Medicine Prediction. | Curr Pharm Biotechnol | 2026 | https://conductscience.org/library/papers/39819398 | PubMed |
| 39804836 | Drug-Drug interactions prediction calculations between cardiovascular drugs and antidepressants for discovering the potential co-medication risks. | PLoS One | 2025 | https://conductscience.org/library/papers/39804836 | PubMed |
| 39647635 | Unlocking biological insights from differentially expressed genes: Concepts, methods, and future perspectives. | J Adv Res | 2025 | https://conductscience.org/library/papers/39647635 | PubMed |
| 39563444 | DrugRepPT: a deep pretraining and fine-tuning framework for drug repositioning based on drug's expression perturbation and treatment effectiveness. | Bioinformatics | 2024 | https://conductscience.org/library/papers/39563444 | PubMed |
| 39339469 | Some Aspects and Convergence of Human and Veterinary Drug Repositioning. | Molecules | 2024 | https://conductscience.org/library/papers/39339469 | PubMed |
| 39312011 | MicroRNA Guided In Silico Drug Repositioning for Malaria. | Acta Parasitol | 2024 | https://conductscience.org/library/papers/39312011 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28334136
GET https://conductscience.org/api/papers/v1/28334136/cited_by?page=2